Please use this identifier to cite or link to this item: https://doi.org/10.1186/s12885-015-1191-3
DC FieldValue
dc.titleCombined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status
dc.contributor.authorChong, Dawn qingqing
dc.contributor.authorToh, Xinyi
dc.contributor.authorHo, Ivyaw
dc.contributor.authorSia, Kianchuan
dc.contributor.authorNewman, Jennifer P.
dc.contributor.authorYulyana, Yulyana
dc.contributor.authorNg, Waihoe
dc.contributor.authorLai, Sianghui
dc.contributor.authorHo, Mac M F
dc.contributor.authorDinesh, Nivedh
dc.contributor.authorTham, Cheekian
dc.contributor.authorLam, Yeng Po Paula
dc.date.accessioned2016-09-09T00:48:41Z
dc.date.available2016-09-09T00:48:41Z
dc.date.issued2015
dc.identifier.citationChong, Dawn qingqing, Toh, Xinyi, Ho, Ivyaw, Sia, Kianchuan, Newman, Jennifer P., Yulyana, Yulyana, Ng, Waihoe, Lai, Sianghui, Ho, Mac M F, Dinesh, Nivedh, Tham, Cheekian, Lam, Yeng Po Paula (2015). Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status. BMC Cancer 15 (1). ScholarBank@NUS Repository. https://doi.org/10.1186/s12885-015-1191-3
dc.identifier.issn14712407
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/127278
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1186/s12885-015-1191-3
dc.publisherBioMed Central
dc.typeArticle
dc.contributor.departmentDUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
dc.description.doi10.1186/s12885-015-1191-3
dc.description.sourcetitleBMC Cancer
dc.description.volume15
dc.description.issue1
dc.identifier.isiut000353319500001
dc.published.statePublished
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.